$VTUS As far as I can tell Assembly has a purely preclinical pipeline, and despite strong venture funding ie. JNJ is probably not worth 20M
<ticker> as far as i can tell assembly has a purely preclinical pipeline , and despite strong venture funding ie . <ticker> is probably not worth <number> m